ghk-cu dosage subcutaneous or topical Guide: Typical Protocols, Injection & GHK-Cu Peptides Before and After:
Description
PMC 9185217

1988 May;85(10):3653-6

In a single-arm clinical study of patients with metastatic angiosarcoma, the inclusion of propranolol or carvedilol in the treatment regimen resulted in a median PFS of 9 and 36 months, respectively, which was significantly longer than the survival in patients who received chemotherapy, radiotherapy, and/or surgery 66 (Table 2)
declare no competing interests
